Nipple Aspirate Fluid Exfoliative Cytopathology and Molecular Biomarkers: Current Role in the Management of Breast Health gives a comprehensive overview of the current and past uses of nipple aspirate fluid (NAF) in breast cancer diagnosis and risk assessment. Topics covered include: - NAF collection methods - analytical validity of NAF cytology - the role of NAF cytology in breast cancer risk stratification - molecular biomarkers found in NAF - risk stratification based on molecular biomarkers in NAF - the effects of ...
Read More
Nipple Aspirate Fluid Exfoliative Cytopathology and Molecular Biomarkers: Current Role in the Management of Breast Health gives a comprehensive overview of the current and past uses of nipple aspirate fluid (NAF) in breast cancer diagnosis and risk assessment. Topics covered include: - NAF collection methods - analytical validity of NAF cytology - the role of NAF cytology in breast cancer risk stratification - molecular biomarkers found in NAF - risk stratification based on molecular biomarkers in NAF - the effects of therapeutic interventions on NAF cytology and biomarkers - pharmacoeconomic evaluation of NAF-based risk assessment - clinical validity and clinical utility of NAF cytopathology Nipple Aspirate Fluid Exfoliative Cytopathology and Molecular Biomarkers is a primer on the advances that have been made regarding NAF cytology and molecular biomarkers, discussing new innovations in the context of past discoveries. It contains indispensable information about a field of breast cancer research that investigators and clinicians alike should be aware of.
Read Less
Add this copy of Nipple Aspirate Fluid Exfoliative Cytopathology and to cart. $53.78, very good condition, Sold by Books From California rated 4.0 out of 5 stars, ships from Simi Valley, CA, UNITED STATES, published 2016 by BookBaby.
Add this copy of Nipple Aspirate Fluid Exfoliative Cytopathology and to cart. $98.75, good condition, Sold by Bonita rated 4.0 out of 5 stars, ships from Newport Coast, CA, UNITED STATES, published 2016 by Atossa Genetics.